Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 186

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 186
---
 common shares underlying Public Warrants that are currently exercisable.

(6)Includes 112,500 common shares underlying stock options that are currently exercisable.

(7) Includes 100,000 common shares underlying stock options that are currently exercisable.

(8) Includes 2,000,000 common shares held of record by 215 Capital Togo PHL Fund I, LP and 6,250 common shares underlying stock options that are currently exercisable. Ajay Raju's address is Two Liberty Place, 50 S. 16th Street, Suite 2710, Philadelphia, PA 19102.

(9)Includes 46,250 common shares underlying stock options that are currently exercisable.

(10)Includes 46,250 common shares underlying stock options that are currently exercisable.

(11)Includes 46,250 common shares underlying stock options that are currently exercisable.

(12)Includes 46,250 common shares underlying stock options that are currently exercisable.

(13)Includes 46,250 common shares underlying stock options that are currently exercisable.

(14)Includes 6,250 common shares underlying stock options that are currently exercisable.

(15)Includes 2,839,330 common shares held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani's address is 1100 Stonegate Manor, Cheswick, PA 15024.

Based upon a review of the information provided to us by our transfer agent, as of September 22, 2025, there were 191 record holders of our common shares,one holder of record of our Public Warrants, one holder of record of our Regulation A Warrants, one holder of record of our June 2030 Warrants and one holder of record of our Private Warrants. Such numbers do not include beneficial owners holding our securities through nominee names.

<div align='center'>131

RELATED PARTY TRANSACTIONS</div>

The Company had an agreement with Velocity Fund Management, LLC ("VFM"), an affiliate of a shareholder of the Company, that provided for certain managerial positions to be filled from within VFM. These employees were not deemed employees of the Company, and VFM was responsible for the payment and provision of all wages, bonuses, commissions and benefits. Reimbursable salaries paid to VFM were approximately $180,000 during the year ended December 31, 2023. This agreement was terminated on September 29, 2023